Metraipolis › archive › dc_dc522046f138
Immune Checkpoint Therapy for Thymic Carcinoma — Europe PMC PMID:41154432
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41154432
- DOI
- 10.3390/cancers17203377
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T04:58:17.621Z
- SHA-256 of the archived text
2581d3b3d4da0ab55855718a7901a0a73d90b5b55b5ee4b7964e5122ba475b80- Stable URL of this page
https://metraipolis.com/documento/dc_dc522046f138
How to cite
Immune Checkpoint Therapy for Thymic Carcinoma — Europe PMC PMID:41154432 — Europe PMC (en), https://europepmc.org/article/MED/41154432 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc522046f138 (Metraipolis archive dc_dc522046f138, sha256 2581d3b3d4da0ab55855718a7901a0a73d90b5b55b5ee4b7964e5122ba475b80)
BibTeX
@misc{dcdc522046f138,
title = {Immune Checkpoint Therapy for Thymic Carcinoma — Europe PMC PMID:41154432},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41154432},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc522046f138; sha256 2581d3b3d4da0ab55855718a7901a0a73d90b5b55b5ee4b7964e5122ba475b80},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41154432. Agents can read the archived copy with the MCP tool read_document.